InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（6 笔）
内部人交易记录
首席财务官已披露买入
0
已披露卖出
6
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the complete record of transactions filed by Kapadia Sandip, 首席财务官. Insider active across 2 companies, notably Harmony Biosciences Holdings, Inc.. Cumulatively, 15 filings have been recorded. Split: 0 buy · 6 sells. Total volume traded: €1.7m. History available since 1 December 2022. The latest transaction was disclosed on 26 January 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Kapadia Sandip
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报15 总计
3,746 股@ US$37.1520.0067% mcap50.0% 占其流量Common StockSEC:0001677141-26-000004:0
3,813 股0Common StockSEC:0001677141-26-000002:0
20,961 股@ US$35.915922.1% 占其流量Common StockSEC:0001677141-26-000001:0
20,000 股@ US$29.0321.9% 占其流量Common StockSEC:0001677141-25-000008:0
3,427 股@ US$35.005.8% 占其流量Common StockSEC:0001677141-25-000006:0
45,000 股0Common StockSEC:0001677141-25-000004:0
21,573 股@ US$36.498340.3% 占其流量Common StockSEC:0001415889-25-022294:0
6,247 股@ US$32.476516.8% 占其流量Common StockSEC:0001415889-25-009936:0
15,000 股0Common StockSEC:0001415889-25-009357:0
3,812 股0Common StockSEC:0001415889-25-002158:0
25,000 股@ US$29.0362.2% 占其流量Common StockSEC:0001415889-25-001925:0
60,000 股0Common StockSEC:0001415889-24-024357:0
15,000 股0Common StockSEC:0001415889-24-009781:0
30,000 股0Common StockSEC:0001415889-23-005668:0
5,000 股@ US$1.1929100.0% 占其流量Common StockSEC:0001209191-22-059462:0
15 条申报中的 15 条
About Kapadia Sandip
Sandip Kapadia is the Chief Financial Officer of Harmony Biosciences Holdings, Inc. He is responsible for the company's financial management, including financial planning, risk management, and financial reporting. His role is essential in ensuring the financial health of the organization and supporting its strategic growth. With extensive expertise in the financial field, he contributes to informed decision-making within the company.
